Search results
Is CRISPR Stock Going to $95? 1 Wall Street Analyst Thinks So. | The Motley Fool
The Motley Fool· 1 day agoCRISPR Therapeutics (CRSP 2.24%) closed last week down 8.5% after reporting first-quarter "earnings"...
Investors Heavily Search CRISPR Therapeutics AG (CRSP): Here is What You Need to Know
Zacks via Yahoo Finance· 3 days agoRecently, Zacks.com users have been paying close attention to CRISPR Therapeutics (CRSP). This makes...
CRISPR can treat common form of inherited blindness, early data hint
Live Science via Yahoo News· 1 day agoA photo shows two male doctors in surgery garb as one preps a long needle for a procedure. A patient...
How Gene Editing Therapies Could Go Beyond Rare Diseases
Forbes· 11 hours agoEarlier this year, a group of scientists in the Netherlands used the gene editing tool CRISPR to...
New strategy suppresses unwanted deletion events to make genome editing safer and more precise
Phys.org· 22 hours agoThis approach tackles a critical issue with CRISPR technology: the act of slicing the genome at...
Gene Editing Breakthrough: CRISPR Improves Vision in Clinical Trial
SciTechDaily· 3 days agoMass Eye and Ear researchers say their findings support continued research and clinical trials of ...
CRISPR Therapeutics’ (CRSP) Neutral Rating Reiterated at Cantor Fitzgerald
ETF DAILY NEWS· 3 days agoCantor Fitzgerald reissued their neutral rating on shares of CRISPR Therapeutics (NASDAQ:CRSP – Free Report) in a research note issued to investors on Thursday, Benzinga reports ...
CRISPR Therapeutics (NASDAQ:CRSP) Stock Price Down 2.1% After Analyst Downgrade
ETF DAILY NEWS· 6 days agoCRISPR Therapeutics AG (NASDAQ:CRSP – Get Free Report) shares dropped 2.1% during trading on Friday after Oppenheimer lowered their price target on the stock from $102.00 ...
Broker Revenue Forecasts For CRISPR Therapeutics AG (NASDAQ:CRSP) Are Surging Higher
Simply Wall St. via Yahoo Finance· 5 days agoCRISPR Therapeutics AG (NASDAQ:CRSP) shareholders will have a reason to smile today, with the...
We're Interested To See How CRISPR Therapeutics (NASDAQ:CRSP) Uses Its Cash Hoard To Grow
Simply Wall St. via Yahoo Finance· 6 days agoNonetheless, only a fool would ignore the risk that a loss making company burns through its cash too...